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Abstract 
Previous studies showed that Leunca herb ethanolic extract (LHE) has cytotoxic 
activity in several cancer cell lines such as HepG2 and HT-29. The extract also demonstrated 
as potential agent to be developed as co-chemotherapeutic in combination with doxorubicin 
and cisplatin. The combination is supposed to reduce occurance of cell resistance and 
toxicity towards normal cell. In order to verify safety before being applied to human, 
toxicological and genotoxic evaluation of the extract is important to be done. This research 
was therefore aimed to investigate acute toxicity and genotoxic activity of LHE. The acute 
toxicity study was carried out in three groups of 5 mice that was orally administrated by LHE 
at different doses consisting 300, 2000 and 5000 mg/kgBW. Mortality and sign of toxicity 
were observed during 7 days. Genotoxic activity was carried out using Mononuclear 
Polychromatic Erythrosite (MNPCE) assay at a doses range of 250, 500, and 1000 mg/kgBW. 
Cyclophosphamide (CYP) at the dose of 50 mg/kg was used as positive control. The result 
showed that LHE did not cause lethal effect on animal model up to doses of 5000 mg/kgBW. 
However, toxicity signs were found in animal model on day 0-6 of the observation. LHE had 
lower genotoxic activity compared to cyclophosphamide at the doses of 250, 500, and 1000 
mg/kg. The low genotoxic activity and acute toxicity of LHE suggested that the extract might 
be safe to be used as medicine. 
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INTRODUCTION 
 
Leunca (Solanum nigrum L.) herb is used 
in Indonesian community as lalapan that is 
served as uncooked vegetable and eaten 
together with rice. Previous studies 
demonstrated that Leunca herb extract is 
potential to be developed as a chemopreventive 
agent due to its activity on some cancer cell 
lines, such as  MCF-7, T47D, and HeLa cells. 
The extract could enhance cytotoxic effects of 
doxorubicin on MCF-7 and T47D breast cancer 
cells and also could increase cytotoxic effects 
of cisplatin on HeLa cervical cancer cells 
(Princess, et al., 2010; Anindyajati, et al., 2010, 
and Istiaji, et al., 2010). Solanine and 
solamargine are known as main active 
compounds that have cytotoxic activity. The 
cytotoxic activity has been reported by 
mechanism of inhibition of  cell cycle on G2/M 
phase arrest and by apoptosis induction through 
a reduction in Bcl-2 expression (Ji, et al., 
2008). 
One of chemotherapy agents commonly 
used in therapy of breast cancer is doxorubicin. 
However, long-term doxorubicin therapy can 
induce cell resistance which is characterized by 
induction of high level P-glycoprotein (Pgp) 
expression in the cells. The overexpression of 
Pgp can cause efflux of chemotherapeutic 
agents in cells, lowering the effects of the 
therapy. Therefore, development of a 
therapeutic agents that can decrease Pgp 
expression in cancer cells is important to be 
done in order to overcome occurence of 
resistance in breast cancer therapy. 
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One of the parameter for a compound's 
genotoxicity is through the  observation of 
micronuleus (Krishna, et al., 2000). 
Micronucleus is a manifestation of the 
mutation. As the the chromosome breaks, it is 
shown as micro-sized nucleus in the cell. 
Micronucleus is easy to find in the 
polychromatic erythrocytes. The number of 
micronucleus polychromatic erythrocyte would 
show the genetic damage in the erythropoetic 
system in organism. One of the compound that 
could evoke MNPCE formation is 
cyclophosphamide. Cyclophosphamide is 
widely used in the treatment of leukemia, 
lymphoblastoma, ovarian cancer, and breast 
cancer. Cyclophosphamide would be active as a 
cancer drug if it has been metabolized by the 
liver first (Anderson, et al., 1995). Then, the 
acute toxicity test was done to determine the 
toxic effect that happend in a short periode that 
is 24 hours after exposure of a single dose 
compound.  
This study was aimed to determine the 
safety of the tested compound. The purposes of 
acute toxicity testing are to obtain information 
on the biologic activity of a chemical and gain 
insight of its mechanism of action. The 
information of acute systemic toxicity 
generated by the test is used in hazard 
identification and risk management in the 
context of production, handling, and use of 
chemicals. The LD50 value is defined as the 
statistically derived dose that, when 
administered in an acute toxicity test, is 
expected to cause death in 50% of the treated 
animals in a given period (Walum, 1998). 
 
MATERIALS AND METHOD 
 
Leunca Ethanolic Extract 
Leunca (Solanum nigrum L.) herb was 
obtained from Balai Besar Penelitian dan 
Pengembangan Tanaman Obat dan Obat 
Tradisional, Tawangmangu, Solo, Central Java, 
Indonesia. As many as 3 kg of leunca powder 
was macerated with 70% ethanol for 5 days. 
The extract was concentrated by rotary vacuum 
evaporator.  
In Vivo Antigenotoxicity Assay 
As many as 35 Balb-c mice aged 6-7 
weeks and weighed 22.5-27.5 g were divided 
into 7 groups, each consisting 5 mice per group. 
Each group was placed in plastic boxes with the 
temperature of 23-25°C and 70-80% humidity. 
The animals were given pellet as meal and 
water ad libitum. The treatment of LHE was 
done for 7 days. Then, the treatment of CYP 
was given with the dose of 50 mg/kgBW for 
two times in the last two days of treatment. In 
the last day of treatment, peripheral blood 
smear were made on microscope slides, 
continued by methanol fixation for 15 minutes, 
and  Giemsa staining (10% in Phosphate Buffer 
Saline (PBS) pH 6.8) for an hour. The slides 
were observed using microscope (Olympus) 
with 1000x magnification. The numbers of 
MNPCE per 1000 Polychromatic Erythrocytes 
(PCE) were counted. In order to avoid the 
negative false results and to know the toxicity 
of the substances administered, the ratio of PCE 
and Normochromatic Erythrocytes (NCE) were 
counted per 2000 NCE+PCE cells. One way 
Anova and Tukey Significancy test (p<0.05) 
statistical analysis were done by using SPSS 
16.0. 
 
In Vivo Accute Toxicity Assay 
As many as 42 Balb-c mice eight weeks 
aged and 190-210 g weighed were divided into 
7 groups. One group was used as control, and 
another five groups were the treated groups. 
Single dose treatment with various dose of LHE 
were given started from the lowest considered 
as the safe dose until the highest dose which 
could make the toxic condition for tested 
animals. Observation of toxicity symptoms, 
manifestation, and mechanism was done for 24 
hours.  
 
RESULT AND DISCUSSION 
 
The Result of Acute Toxicity Assay 
The treatment of LHE in the dose of 300, 
2000, and 5000 mg/kgBW showed the toxic 
symptom as shown in Balazs (1970)  table in 
the initial hours until six hours later (Table 3). 
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The toxic symptom was not showed eight hours 
until seven days later. 
According to the observation, toxic 
symptoms of LHE appeared in the initial hours 
until six hours later, but the toxic symptoms did 
not appear after the eighth hour until seven days 
later. No death observed because leunca 
ethanolic extract did not affect performance of 
the vital organs. The observation was done 
macroscopically which showed the toxic 
symptom. 
The toxic condition is including the 
death of animal tested which was used to decide 
the potential of acute toxicity (LD50) of LHE. 
This observation showed that the treatment of 
LHE in the highest dos (1000 mg/kgBW), 
didn’t cause the death of the animal groups. It 
means that LHE is not toxic at the treatment 
doses. Therefore, the LD50 could not be 
determined in this study. 
 
The Result of In Vivo Antigenotoxicity 
Assay 
The antigenotoxic effect of LHE can be 
determined by the parameter of MNPCE/1000 
PCE and PCE/PCE+NCE ratio per 2000 cells. 
Based on this study, the doses of 250; 500; and 
1000 mg/kgBW LHE could reduce the number 
of MNPCE/1000 PCE compared to the CYP 
control group (Table 1). This ressult showed the 
effect of LHE in the inhibition of genetis 
damage in the erythropoietic system induced by 
CYP. Besides that, LHE could also increase the 
parameter of PCE/PCE+NCE ratio per 2000 
cells compared to the CYP control group (Table 
II). It showed that LHE didn’t cause DNA 
toxicity.  
 
 
 
 
Table 1. Balazs table (Balazs T., 1970) 
Organ system 
Observatioun and 
examination 
Common signs of toxicity 
CNS and 
somatomotor 
behaviour 
unusual aggressiveness, unusual vocalization, restlessness, 
sedation. 
movements twitch, tremor, ataxia, catatoni, paralysis, convulsion 
reactivity to various 
stimuli 
irritability, passivity, anesthesia, hyperesthesia 
Respiratory character and rate Bradypnoea, dyspnoea,  
Cardiovascular 
palpation of cardiac 
region 
Bradycardia, arrhythmia 
Gastrointestinal 
events Diarrhea, constipation 
feces consistency unformed 
Skin and fur color, turgor, intergrity piloerection, reddening, eruptions 
Other general condition abnormal posture, emaciation 
 
 
 
  
Rumiyati, et al., 2015 
Indones. J. Cancer Chemoprevent., 6(1), 30-34  
33 
 
Table 2. The antigenotoxic effect as the parameter of MNPCE/1000 PCE 
 
Groups 
MNPCE / 1000  PCE 
Replication 
 1 
Replication 
2 
Replication 
3 
Replication 
4 
Average 
Negative control 8 6 10 10 8.5 
CYP control 33 39 37 40 37.25 
1000 mg/kgBW of LHE control  5 4 6 3 4.5 
Solvent control 7 7 8 12 8.5 
250 mg/kgBW of LHE + CYP 21 26 28 25 25 
500 mg/kgBW of LHE + CYP 14 17 11 16 14.5 
1000 mg/kgBW of LHE + CYP 9 7 9 12 9.25 
 
 
 
Table 3. The antigenotoxic effect as the parameter of PCE/PCE+NCE ratio per 2000 cells 
 
Groups 
PCE / PCE+NCE (2000 cells) 
Replication 
 1 
Replication 
2 
Replication 
3 
Replication 
4 
Average 
Negative control 52 46 52 46 49 
CYP control 24 20 23 21 22 
1000 mg/kgBW of LHE 
control  
53 49 55 52 52.25 
Solvent control 54 44 50 46 48.5 
250 mg/kgBW of LHE + CYP 35 38 35 25 33.25 
500 mg/kgBW of LHE + CYP 39 43 37 30 37.25 
1000 mg/kgBW of LHE + 
CYP 
47 46 51 45 47.25 
 
 
The result of MNCEP, PCE, and NCE  
were observed by Light microscope with 1000 
times magnification. The morphology of that 
kind of cells  were shown in Fig. 1. 
 
CONCLUSION 
 
  The effect of LHE showed in the 
inhibition of genetic damage in the 
erythropoietic system induced by 
cyclophosphamide. The treatment of LHE 
could increase the PCE/PCE+NCE ratio per 
2000 cells compared to the cyclophosphamide 
control group, so leunca does not cause DNA 
toxicity. 
  The treatment of LHE did not cause 
lethal effect on animal model up to doses of  
5000 mg/BW. However, toxicity signs were 
found in animal model on day 0-6 of the 
observation. 
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Figure 1 . MNPCE, PCE, and NCE appearance in blood semar preparat of animal treatment group. 
The red arrow (         ) showed the MNPCE, the young erythrocyte contains micronucleus and stained 
purple with dot. The blue arrow (         ) showed PCE, the young erythrocyte without micronucleus and 
stained purple without dot. The yellow arrow (         ) showed NCE, the mature erythrocyte without 
nucleus and was not stained  purple. 
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